Role of 5-HT in stress, anxiety, and depression

[1]  K. Montgomery,et al.  The relation between fear induced by novel stimulation and exploratory drive. , 1955 .

[2]  A. Coppen.  The Biochemistry of Affective Disorders , 1967, British Journal of Psychiatry.

[3]  L Stein,et al.  Benzodiazepines: Anxiety-Reducing Activity by Reduction of Serotonin Turnover in the Brain , 1972, Science.

[4]  S. Iversen,et al.  5-Hydroxytryptamine and punishment , 1977, Nature.

[5]  E. Azmitia.  The Serotonin-Producing Neurons of the Midbrain Median and Dorsal Raphe Nuclei , 1978 .

[6]  L. Takahashi,et al.  Effects of median raphe nucleus lesions on hippocampal EEG in the freely moving rat , 1979, Brain Research.

[7]  A. Jobert,et al.  Chlordiazepoxide and GABA injected into raphé dorsalis release the conditioned behavioural suppression induced in rats by a conflict procedure without nociceptive component , 1980, Neuropharmacology.

[8]  W. Weiner,et al.  Modification of central serotonergic and dopaminergic behaviors in the course of chronic corticosteroid administration. , 1982, European journal of pharmacology.

[9]  S. Iversen.  5-HT and anxiety , 1984, Neuropharmacology.

[10]  G. Kennett,et al.  Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats , 1985, Brain Research.

[11]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[12]  G. Kennett,et al.  Reduced 5-hydroxytryptamine-dependent behaviour in rats following chronic corticosterone treatment , 1985, Brain Research.

[13]  G. Kennett,et al.  Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone. , 1985, European journal of pharmacology.

[14]  K. Hoshino,et al.  Ulcerogenic effect of the lesion of the median raphe nucleus in fasted rats. , 1986, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[15]  B. J. Jones,et al.  Microinjections of methyl-β-carboline-3-carboxylate into the dorsal raphe nucleus: Behavioural consequences , 1986, Pharmacology Biochemistry and Behavior.

[16]  G. Kennett,et al.  Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. , 1987, European journal of pharmacology.

[17]  C. de Montigny,et al.  Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression , 1987, Journal of clinical psychopharmacology.

[18]  R. Kahn,et al.  Serotonin and anxiety revisited , 1988, Biological Psychiatry.

[19]  S. Iversen,et al.  Handbook of Psychopharmacology , 1988, Springer US.

[20]  S. Hjorth,et al.  Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test , 1989, Pharmacology Biochemistry and Behavior.

[21]  A. Björklund,et al.  Hippocampal Noradrenaline and Serotonin Release over 24 Hours as Measured by the Dialysis Technique in Freely Moving Rats: Correlation to Behavioural Activity State, Effect of Handling and Tail‐Pinch , 1989, The European journal of neuroscience.

[22]  S. Targum,et al.  Fenfluramine provocation of anxiety in patients with panic disorder , 1989, Psychiatry Research.

[23]  D. Blanchard,et al.  Ethoexperimental approaches to the study of behavior , 1989 .

[24]  J. Popova,et al.  Changes in 5-HT1 receptors in different brain structures of rats with isolation syndrome. , 1990 .

[25]  New concepts in anxiety , 1990 .

[26]  G. Burrows,et al.  The Neurobiology of Anxiety , 1990 .

[27]  E. Čechová,et al.  Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex , 1990, Brain Research.

[28]  P. Willner.  Animal models of depression: an overview. , 1990, Pharmacology & therapeutics.

[29]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[30]  Bruce S. McEwen,et al.  Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons , 1990, Brain Research.

[31]  T. Sharp,et al.  Behavioural evidence for a functional interaction between central 5‐HT2 and 5‐HT1A receptors , 1990, British journal of pharmacology.

[32]  W. Hesen,et al.  Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  N. McNaughton,et al.  Buspirone affects hippocampal rhythmical slow activity through serotonin1A rather than dopamine D2 receptors , 1991, Neuroscience.

[34]  M. Molliver,et al.  Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5‐HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives , 1991, The Journal of comparative neurology.

[35]  D. Nutt.  Anxiety and Its Therapy: Today and Tomorrow , 1991 .

[36]  J. Deakin,et al.  5-HT and mechanisms of defence , 1991, Journal of psychopharmacology.

[37]  T. Curran,et al.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. , 1991, Annual review of neuroscience.

[38]  J. Deakin,et al.  5-HT Receptor Mechanisms in Human Anxiety , 1991 .

[39]  H. Kremer,et al.  The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease , 1991, Neuroscience Letters.

[40]  C. Marsden,et al.  Central serotonin receptors and psychotropic drugs , 1992 .

[41]  L. Ballerini,et al.  Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices , 1992, Neuroscience.

[42]  M. Carli,et al.  8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task. , 1992, European journal of pharmacology.

[43]  T. Patterson,et al.  The Relationship of Life Adversity, Social Support, and Coping to Hospitalization with Major Depression , 1992, The Journal of nervous and mental disease.

[44]  S. Korte,et al.  Adrenal hormones in rats before and after stress-experience: Effects of ipsapirone , 1992, Physiology & Behavior.

[45]  M. Carli,et al.  8‐Hydroxy‐2‐(di‐n‐propylamino)tetralin impairs spatial learning in a water maze: role of postsynaptic 5‐HT1A receptors , 1992, British journal of pharmacology.

[46]  M. Carli,et al.  Stimulation of 5-HT1A receptors in the dorsal hippocampus impairs acquisition and performance of a spatial task in a water maze , 1992, Brain Research.

[47]  K. Krishnan,et al.  Adrenal gland enlargement in major depression. A computed tomographic study. , 1992, Archives of general psychiatry.

[48]  5 ht receptor subtypes and the modulation of aversion , 1992 .

[49]  B. McEwen,et al.  The Vulnerability of the Hippocampus to Protective and Destructive Effects of Glucocorticoids in Relation to Stress , 1992, British Journal of Psychiatry.

[50]  B. Peeters,et al.  The involvement of glucocorticoids in the acquired immobility response is dependent on the water temperature , 1992, Physiology & Behavior.

[51]  Gilles Bonvento,et al.  Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain , 1992, Neuroscience Letters.

[52]  D. McTavish,et al.  Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity. , 1992, Drugs.

[53]  R. Anwyl,et al.  Serotoninergic depression of auditory evoked responses recorded in the rat hippocampus: effect of repeated buspirone treatment , 1992, Brain Research.

[54]  B. McEwen,et al.  Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. , 1992, Neuroendocrinology.

[55]  H. Anisman,et al.  The Impact of Stressors on Immune and Central Neurotransmitter Activity: Bidirectional Communication , 1993, Reviews in the neurosciences.

[56]  F. Graeff.  Role of 5-HT in Defensive Behavior and Anxiety , 1993, Reviews in the neurosciences.

[57]  S. Maier,et al.  The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock. , 1993, Behavioral neuroscience.

[58]  B. Lerer,et al.  Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients , 1993, Biological Psychiatry.

[59]  D. Johnston,et al.  Serotonin inhibits induction of long-term potentiation at commissural synapses in hippocampus , 1993, Brain Research.

[60]  M Briley,et al.  Neurobiological mechanisms involved in antidepressant therapies. , 1993, Clinical neuropharmacology.

[61]  R. Kessler,et al.  The prediction of major depression in women: toward an integrated etiologic model. , 1993, The American journal of psychiatry.

[62]  C. Tanaka,et al.  Inhibitory modulation of long-term potentiation via the 5-HT1A receptor in slices of the rat hippocampal dentate gyrus , 1993, Brain Research.

[63]  F. Graeff,et al.  The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. , 1993, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[64]  F. Graeff,et al.  Role of the amygdala and periaqueductal gray in anxiety and panic , 1993, Behavioural Brain Research.

[65]  M. Palkovits,et al.  5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.

[66]  H. Akil,et al.  Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[67]  N. Nomura,et al.  Differential effect of subchronic dexamethasone treatment on serotonin-2 and β-adrenergic receptors in the rat cerebral cortex and hippocampus , 1993, Neuroscience Letters.

[68]  R. Rubin,et al.  Adrenal gland enlargement in major depression. , 1993, Archives of general psychiatry.

[69]  M. Ohno,et al.  Working memory deficits induced by intrahippocampal administration of 8-OH-DPAT, a 5-HT1A receptor agonist, in the rat. , 1993, European journal of pharmacology.

[70]  F. Artigas.  5-HT and antidepressants: new views from microdialysis studies. , 1993, Trends in pharmacological sciences.

[71]  Attenuation of behavioral consequences of immobilization stress by intra-hippocampal microinjection of zimelidine. , 1993, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[72]  F. Graeff,et al.  D-fenfluramine reduces anxiety induced by simulated public speaking. , 1993, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[73]  I. K. Wright,et al.  Social isolation attenuates rat forebrain 5‐HT release induced by KCl stimulation and exposure to a novel environment , 1993, Behavioural pharmacology.

[74]  A. Baum,et al.  Control and intrusive memories as possible determinants of chronic stress. , 1993, Psychosomatic medicine.

[75]  D. Treit,et al.  Anxiogenic stimuli in the elevated plus-maze , 1993, Pharmacology Biochemistry and Behavior.

[76]  F. Guimarães,et al.  Hippocampal 5-HT receptors and consolidation of stressful memories , 1993, Behavioural Brain Research.

[77]  Controlling panic attacks with fenfluramine. , 1994, The American journal of psychiatry.

[78]  S. Maier,et al.  Chlordiazepoxide microinjected into the region of the dorsal raphe nucleus eliminates the interference with escape responding produced by inescapable shock whether administered before inescapable shock or escape testing. , 1994, Behavioral neuroscience.

[79]  Carmen Sandi,et al.  Corticosterone enhances long-term retention in one-day-old chicks trained in a weak passive avoidance learning paradigm , 1994, Brain Research.

[80]  F. Graeff,et al.  The elevated T-maze: A new animal model of anxiety and memory , 1994, Pharmacology Biochemistry and Behavior.

[81]  Stress-induced expression of the c-fos proto-oncogene in the hippocampal formation. , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[82]  H. Akil,et al.  Regulation of Hippocampal 5-HT1A Receptor Gene Expression by Dexamethasone , 1994, Neuropsychopharmacology.

[83]  B. Peeters,et al.  Involvement of corticosteroids in the processing of stressful life-events. A possible implication for the development of depression , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[84]  T. Dinan.  Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model , 1994, British Journal of Psychiatry.

[85]  C. McKittrick,et al.  Serotonin receptor binding in a colony model of chronic social stress , 1995, Biological Psychiatry.

[86]  T. Dinan,et al.  Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression , 1995, Biological Psychiatry.

[87]  5HT2 receptors and anxiety: 6.5 , 1995 .

[88]  S. Checkley,et al.  Treatment of major depression with metyrapone and hydrocortisone. , 1995, Journal of affective disorders.

[89]  D-fenfluramine selectively releases 5-HT from dorsal raphe terminals. , 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[90]  S. Netto,et al.  Role of hippocampal 5-HT1A receptors on elevated plus maze exploration after a single restraint experience , 1996, Behavioural Brain Research.

[91]  F. Graeff,et al.  Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze , 1996, Pharmacology Biochemistry and Behavior.

[92]  F. Graeff,et al.  Dual role of 5-HT in defense and anxiety , 1997, Neuroscience & Biobehavioral Reviews.